News

Schering-Plough has announced that EMEA has accepted its Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate, for the maintenance treatment of asthma

Viral Genetics has issued this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on

As per lawsuit, Abbott has willfully undertaken and carried out the aforesaid infringing activity with knowledge of” the patent. Previously, Bruce Saffran has won a patent infringement suit

BioAlliance Pharma has reported positive preliminary results for its LIP phase III pivotal, multicenter randomised, double-blind, placebo controlled study (Lauriad Immunocompetent Patients Study). The company said that this

Transcend services (Transcend) has entered into an agreement to acquire Medical Dictation Services (MDI) for $16.2m. Reportedly, the $16.2m purchase price consists of $10m in cash payable at

CEL -SCI is expanding the scope of its work for creating a new treatment and vaccination against the current H1N1 virus, and a future mutated form in which

Provectus has added Mount Sinai School of Medicine as its second and final site for its expanded phase 2 clinical trial of dermatology agent PH-10 for psoriasis. Jason

Switzerland-based plasma products manufacturer, Octapharma is guiding an international initiative focused on confronting the risk associated with hemophilia A therapy – anti-factor VIII (FVIII) antibodies, also known as

QRxPharma has completed its pilot study to evaluate the analgesic efficacy and safety profile of MoxDuo IR capsules in patients with moderate to severe pain following total knee